News

News

LNC Therapeutics announces the deployment of a research platform focused exclusively on its gut...

Jun 6, 2019

more +
News

LNC Therapeutics announces the grant of the first worldwide patent relating to the therapeutic...

Mar 26, 2019

more +
News

Dr. Mathieu Simon and Catherine Combot-Plétan join the Board of Directors of biotech firm LNC...

Dec 11, 2018

more +
News

LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University

Oct 15, 2018

more +
News

LNC Therapeutics launches a new clinical trial, OBEMINALE 2, and treats its first patient

Oct 2, 2018

more +
News

Christensenella: the cornerstone of the gut microbiota?

Jul 6, 2018

more +

LNC Therapeutics © 2020 - all rights reserved terms and conditions